Skip to content

Collagen Cross-linking in Infectious Keratitis Trial

Collagen Cross-linking in Infectious Keratitis Trial

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01831206
Enrollment
30
Registered
2013-04-15
Start date
2013-03-31
Completion date
2014-12-31
Last updated
2015-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious Keratitis, Bacterial Keratitis, Fungal Keratitis

Keywords

corneal ulcer, keratitis

Brief summary

The purpose of this study is to evaluate the efficacy of collagen cross-linking for treatment of infectious keratitis.

Interventions

Collagen cross-linking arm will receive standard medication for corneal ulcer treatment and corneal collagen cross-linking. Standard treatment arm will receive only standard medication.

Sponsors

Chulalongkorn University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Evidence of corneal ulcer grade II or III (bacteria or fungal, or presumed bacterial or fungal) * Age more than 6 year * Patients can understand and can follow the study protocol

Exclusion criteria

* Pregnancy by history or urine test * Evidence of herpetic keratitis * Evidence of corneal perforation * Evidence of autoimmune disease * Known allergy to study medication

Design outcomes

Primary

MeasureTime frameDescription
decrement of infiltration size1 monthsdecrement of infiltration size between day0 and day 30

Secondary

MeasureTime frameDescription
number of participants with adverse events1 monthsadverse events after corneal collagen cross-linking (report in descriptive study)

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026